Skip to content

ROCHE: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

ROCHE

BE 0403.088.151
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE division 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations all sizesfiscal years 2021 to 202533 to 173 sector peers per ratio

Summary

fiscal year 2025

ROCHE does better than half of its sector on 6 of the 13 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Interest coveragebetter than 88%
  • Days inventorybetter than 71%
  • Return on assetsbetter than 61%
Points to watch
  • EBITDA marginbetter than 20%
  • Gross marginbetter than 25%
  • Debt to equitybetter than 26%

Solvency and debt

How soundly the company is financed.
Solvency
39.1%▲2025

Solvency is below 59% of 171 sector peers: less favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Debt to equity
1.52▲2025

Debt to equity is above 74% of 169 sector peers: less favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Interest coverage
237.78▲2025

Interest coverage is above 88% of 148 sector peers: in the most favourable quarter.

Position against the sector improving since 2021.

20212022202320242025

Liquidity

Whether it can pay its short-term bills.
Current ratio
1.62▼2025

The current ratio is below 52% of 170 sector peers: less favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Quick ratio
1.05▼2025

The quick ratio is below 55% of 170 sector peers: less favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Working-capital ratio
36.8%▼2025

The working-capital ratio is above 60% of 171 sector peers: more favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025

Profitability

What the company earns on its assets and its sales.
Return on equity
13.6%▼2025

Return on equity is above 59% of 145 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Return on assets
5.3%▼2025

Return on assets is above 61% of 173 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Net margin
1.9%▼2025

The net margin is below 70% of 38 sector peers: less favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025
EBITDA margin
2.9%▼2025

The EBITDA margin is below 80% of 37 sector peers: in the least favourable quarter.

Position against the sector stable since 2021.

20212022202320242025
Gross margin
42.1%▼2025

The gross margin is below 75% of 38 sector peers: in the least favourable quarter.

Position against the sector stable since 2021.

20212022202320242025

Working-capital cycle

How long cash is tied up in customers, suppliers and stock.
Days sales outstanding
54days▲2025

Days sales outstanding is below 51% of 38 sector peers: more favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025
Days payable outstanding
109days▲2025

Days payable outstanding is above 57% of 40 sector peers.

20212022202320242025
Days inventory
79days▲2025

Days inventory is below 71% of 33 sector peers: more favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025

Not computable

Long-term debt ratio. The filed figures do not contain the lines these need.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.